Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors

被引:19
|
作者
Cheng, Xian-Chao [1 ]
Fang, Hao [1 ]
Xu, Wen-Fang [1 ]
机构
[1] Shandong Univ, Inst Med Chem, Sch Pharmaceut Sci, Jinan 250012, Peoples R China
关键词
matrix metalloproteinases; inhibitors; assays;
D O I
10.1080/14756360701511292
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) play an important role in many physiological and pathological processes. To assay the activities of MMPs is important in diagnosis and therapy of the MMPs associated diseases, such as neoplastic, rheumatic and cardiovascular diseases. Several assay systems have been developed, which include bioassay, zymography assay, immunoassay, fluorimetric assay, radio isotopic assay, phage-displayed assay, multiple-enzyme/multiple-reagent assay and activity-based profiling assay. The principle, application, advantage and disadvantage of these assays have been reviewed in this article.
引用
收藏
页码:154 / 167
页数:14
相关论文
共 50 条
  • [41] Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness
    Carrick-Ranson, Graeme
    Spinale, Francis G.
    Bhella, Paul S.
    Sarma, Satyam
    Shibata, Shigeki
    Fujimoto, Naoki
    Hastings, Jeffrey L.
    Levine, Benjamin D.
    EXPERIMENTAL GERONTOLOGY, 2019, 123 : 36 - 44
  • [42] Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases
    Gueders, MM
    Foidart, JM
    Noel, A
    Cataldo, DD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 533 (1-3) : 133 - 144
  • [43] The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?
    M. G. Belvisi
    K. M. Bottomley
    Inflammation Research, 2003, 52 : 95 - 100
  • [44] The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?
    Belvisi, MG
    Bottomley, KM
    INFLAMMATION RESEARCH, 2003, 52 (03) : 95 - 100
  • [45] Differential release of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in patients following alcohol induced myocardial infarction
    Bradham, WS
    Gunasinghe, H
    Wendt, KA
    Holder, J
    Multani, M
    Spencer, W
    Killip, D
    Anderson, M
    Meyer, D
    Spinale, FG
    CIRCULATION, 2001, 104 (17) : 305 - 305
  • [46] Activity and expression profiling of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the hearts with doxorubicin-induced cardiomyopathy
    Lin, C. S.
    Kuan, T-C.
    Lai, S-C.
    Chen, M-Y.
    Wu, H-T.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S121 - S121
  • [47] Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) as clinical markers of disease: Past, present, and future
    Zucker, S
    TISSUE INHIBITORS OF METALLOPROTEINASES IN DEVELOPMENT AND DISEASE, PROCEEDINGS, 2000, : 163 - 170
  • [48] Involvement of ERK-MAPK and PKC in the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in astrocytes
    He, S
    Prasanna, G
    Yorio, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [49] Evaluation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in human cases with orofacial clefts: A systematic review
    Imani, Mohammad Moslem
    Shalchi, Majid
    Ahmadabadi, Gholamhassan
    Sadeghi, Masoud
    INTERNATIONAL ORTHODONTICS, 2023, 21 (03)
  • [50] Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.
    Dimov, Dimo
    Tacheva, Tanya
    Ivanova, Donika
    Zhelyazkova, Yanitsa
    Vlaykova, Denitsa
    Gulubova, Maya
    Vlaykova, Tatyana
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52